Case of successfully switching from nivolumab to vemurafenib with oral corticosteroids

J Dermatol. 2018 Jun;45(6):e156. doi: 10.1111/1346-8138.14199. Epub 2018 Jan 6.

Authors

Keisuke Imafuku^{1

2}, Koji Yoshino¹, Kei Yamaguchi¹, Satoshi Tsuboi¹, Kuniaki Ohara¹, Hiroo Hata²

Affiliations

¹ Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
² Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

PMID: 29315740
DOI: 10.1111/1346-8138.14199

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Aged
Betamethasone / administration & dosage
Drug Eruptions / etiology
Drug Eruptions / prevention & control*
Drug Substitution / adverse effects*
Female
Glucocorticoids / administration & dosage*
Humans
Melanoma / drug therapy
Melanoma / pathology
Nivolumab / therapeutic use*
Skin Neoplasms / drug therapy
Skin Neoplasms / pathology
Treatment Outcome
Vemurafenib / therapeutic use*

Substances

Glucocorticoids
Vemurafenib
Nivolumab
Betamethasone